speb/financial-data huggingface dataset:
MCHPP balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 633400000.00
MCHPP balance_sheet (annual, 2025-03-31) — Treasury Shares Number: 39292311.00
MCHPP balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 39292311.00
MCHPP balance_sheet (annual, 2025-03-31) — Treasury Stock: 2611600000.00
MCHPP balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 2611600000.00
MCHPP balance_sheet (annual, 2025-03-31) — Work In Process: 857600000.00
MCHPP balance_sheet (quarterly, 2025-03-31) — Work In Process: 857600000.00
MCHPP balance_sheet (annual, 2025-03-31) — Working Capital: 1836200000.00
MCHPP balance_sheet (quarterly, 2025-03-31) — Working Capital: 1836200000.00
MCHPP income_statement (quarterly, 2025-06-30) — +Operating Expense: 522400000.00
MCHPP income_statement (quarterly, 2025-06-30) — +Total Revenue: 1075500000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 161900000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 755100000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2374900000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 3974000000.00
MCHPP income_statement (quarterly, 2025-06-30) — Amortization: 107600000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 131600000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 131600000.00
MCHPP income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 107600000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 2200000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 771700000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 702500000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -17900000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -17900000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 36400000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Capital Stock: 600000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 566500000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 566500000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -270600000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -443900000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -36900000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 275600000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 27600000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: -4600000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Change In Inventory: 125000000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -3400000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Change In Payable: 23000000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 23000000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Change In Receivables: -75800000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -4600000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 68800000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -75800000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Changes In Cash: -205200000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Common Stock: 600000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -245500000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 6857100000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 12400000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 428400000.00
MCHPP income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 498800000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 251200000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Current Assets: 2753800000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 36400000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 36400000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 160100000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 160100000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1190400000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Current Provisions: 365400000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -3000000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Deferred Tax: -3000000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Depreciation: 39500000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 171100000.00
MCHPP income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 107600000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 171100000.00
MCHPP income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 107600000.00
MCHPP income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -46400000.00
MCHPP income_statement (quarterly, 2025-06-30) — EBIT: 40200000.00
MCHPP income_statement (quarterly, 2025-06-30) — EBITDA: 211300000.00
MCHPP cash_flow (quarterly, 2025-06-30) — End Cash Position: 566500000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -443900000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Finished Goods: 210100000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 257700000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -6400000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Goodwill: 6695400000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 8987600000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Gross PPE: 3528800000.00
MCHPP income_statement (quarterly, 2025-06-30) — Gross Profit: 576700000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 86200000.00
MCHPP income_statement (quarterly, 2025-06-30) — Interest Expense: 56000000.00
MCHPP income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 56000000.00
MCHPP income_statement (quarterly, 2025-06-30) — Interest Income: 4900000.00
MCHPP income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 4900000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Inventory: 1169100000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Invested Capital: 12315200000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -36900000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 12400000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 84800000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 5458100000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 5458100000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
MCHPP cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -400000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 2313100000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 12400000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Net Debt: 4891600000.00
MCHPP income_statement (quarterly, 2025-06-30) — Net Income: -18600000.00
MCHPP income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -46400000.00
MCHPP income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -18600000.00
MCHPP income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -18600000.00
MCHPP income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -18600000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -18600000.00
MCHPP income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -18600000.00
MCHPP income_statement (quarterly, 2025-06-30) — Net Interest Income: -52500000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -174500000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -400000.00
MCHPP income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -52500000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -11200000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -19000000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Net PPE: 1153900000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -174100000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -2130500000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 1734600000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 36300000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 1734600000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 36300000.00
MCHPP income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 233500000.00
MCHPP income_statement (quarterly, 2025-06-30) — Normalized Income: -1062000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 275600000.00
MCHPP income_statement (quarterly, 2025-06-30) — Operating Income: 54300000.00
MCHPP income_statement (quarterly, 2025-06-30) — Operating Revenue: 1075500000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 539676850.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 252700000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -6400000.00
MCHPP income_statement (quarterly, 2025-06-30) — Other Income Expense: -17600000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 2292200000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2200000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 349600000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 797400000.00
MCHPP income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 4600000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Other Receivables: 16100000.00
MCHPP income_statement (quarterly, 2025-06-30) — Other Special Charges: 22200000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Payables: 248100000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 499300000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 129200000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
MCHPP cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: -25100000.00
MCHPP income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 27800000.00
MCHPP income_statement (quarterly, 2025-06-30) — Pretax Income: -15800000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Raw Materials: 165800000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Receivables: 765500000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -5700000.00
MCHPP income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 435300000.00
MCHPP income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 171100000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -174500000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
MCHPP income_statement (quarterly, 2025-06-30) — Research And Development: 255500000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 5489200000.00
MCHPP income_statement (quarterly, 2025-06-30) — Selling General And Administration: 159300000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Share Issued: 578423869.00
MCHPP cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 0.00
MCHPP cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -174100000.00
MCHPP income_statement (quarterly, 2025-06-30) — Special Income Charges: -22200000.00
MCHPP cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 52900000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 6857100000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -2130500000.00
MCHPP income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -4662000.00
MCHPP income_statement (quarterly, 2025-06-30) — Tax Provision: 2800000.00
MCHPP income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
MCHPP balance_sheet (quarterly, 2025-06-30) — Total Assets: 14979500000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 12315200000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Total Debt: 5494500000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 6857100000.00
MCHPP income_statement (quarterly, 2025-06-30) — Total Expenses: 1021200000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 8122400000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 12225700000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 6932000000.00
MCHPP income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 32100000.00
MCHPP income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 1400000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 86200000.00
MCHPP income_statement (quarterly, 2025-06-30) — Total Unusual Items: -22200000.00
MCHPP income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -22200000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 640200000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 38747019.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 2600300000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Work In Process: 793200000.00
MCHPP balance_sheet (quarterly, 2025-06-30) — Working Capital: 1563400000.00
MCHPP income_statement (quarterly, 2025-09-30) — +Operating Expense: 542700000.00
MCHPP income_statement (quarterly, 2025-09-30) — +Total Revenue: 1140400000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 170000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 737000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -2517000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 4028500000.00
MCHPP income_statement (quarterly, 2025-09-30) — Amortization: 108100000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 133700000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 133700000.00
MCHPP income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 108100000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 300000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 566500000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 710800000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -36500000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -36500000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 36800000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Capital Stock: 600000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 236800000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 236800000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -273600000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -355800000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -62000000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 88100000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -53600000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: -174800000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Change In Inventory: 76000000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -72400000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Change In Payable: -228400000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -228400000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Change In Receivables: 19900000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: -174800000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -204900000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 19900000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Changes In Cash: -329700000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Common Stock: 600000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -245800000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6695500000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 17900000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 428800000.00
MCHPP income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 502500000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 211000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Current Assets: 2350300000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 36800000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 36800000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 160000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 160000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1043800000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Current Provisions: 349000000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 5300000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Deferred Tax: 5300000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Depreciation: 39000000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 172700000.00
MCHPP income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 108100000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 172700000.00
MCHPP income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 108100000.00
MCHPP income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 13900000.00
MCHPP income_statement (quarterly, 2025-09-30) — EBIT: 86800000.00
MCHPP income_statement (quarterly, 2025-09-30) — EBITDA: 259500000.00
MCHPP cash_flow (quarterly, 2025-09-30) — End Cash Position: 236800000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -355800000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Finished Goods: 194700000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 51600000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -6200000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Goodwill: 6695500000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 8865000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3670500000.00
MCHPP income_statement (quarterly, 2025-09-30) — Gross Profit: 637900000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 0.00
MCHPP income_statement (quarterly, 2025-09-30) — Interest Expense: 55000000.00
MCHPP income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 55000000.00
MCHPP income_statement (quarterly, 2025-09-30) — Interest Income: 3600000.00
MCHPP income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 3600000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Inventory: 1095300000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Invested Capital: 12071400000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -62000000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 17900000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 1588400000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 99600000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 5375900000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 5375900000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 1588400000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1850500000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 2431300000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 17900000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Net Debt: 5139100000.00
MCHPP income_statement (quarterly, 2025-09-30) — Net Income: 41700000.00
MCHPP income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 13900000.00
MCHPP income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 41700000.00
MCHPP income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 41700000.00
MCHPP income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 41700000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 41700000.00
MCHPP income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 41700000.00
MCHPP income_statement (quarterly, 2025-09-30) — Net Interest Income: -52700000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -88000000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -262100000.00
MCHPP income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -52700000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -12100000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -25500000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Net PPE: 1153500000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -2169500000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 1739000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 35200000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 1739000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 35200000.00
MCHPP income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 265800000.00
MCHPP income_statement (quarterly, 2025-09-30) — Normalized Income: 46677000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 88100000.00
MCHPP income_statement (quarterly, 2025-09-30) — Operating Income: 95200000.00
MCHPP income_statement (quarterly, 2025-09-30) — Operating Revenue: 1140400000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 540446319.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 272000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -6200000.00
MCHPP income_statement (quarterly, 2025-09-30) — Other Income Expense: -10700000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2169500000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 11400000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 361900000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 758200000.00
MCHPP income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -4400000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Other Receivables: 14800000.00
MCHPP income_statement (quarterly, 2025-09-30) — Other Special Charges: 6300000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Payables: 170000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 381000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 117000000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
MCHPP cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -27800000.00
MCHPP income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 27800000.00
MCHPP income_statement (quarterly, 2025-09-30) — Pretax Income: 31800000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Raw Materials: 140400000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Receivables: 746200000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -5600000.00
MCHPP income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 437900000.00
MCHPP income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 172700000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1676400000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
MCHPP income_statement (quarterly, 2025-09-30) — Research And Development: 262300000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 5257300000.00
MCHPP income_statement (quarterly, 2025-09-30) — Selling General And Administration: 172300000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Share Issued: 578423869.00
MCHPP income_statement (quarterly, 2025-09-30) — Special Income Charges: -6300000.00
MCHPP cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 61600000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6695500000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -2169500000.00
MCHPP income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1323000.00
MCHPP income_statement (quarterly, 2025-09-30) — Tax Provision: -9900000.00
MCHPP income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
MCHPP balance_sheet (quarterly, 2025-09-30) — Total Assets: 14469700000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 12071400000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Total Debt: 5412700000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 6695500000.00
MCHPP income_statement (quarterly, 2025-09-30) — Total Expenses: 1045200000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 7774200000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 12119400000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 6730400000.00
MCHPP income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 88900000.00
MCHPP income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 1300000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 0.00
MCHPP income_statement (quarterly, 2025-09-30) — Total Unusual Items: -6300000.00
MCHPP income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -6300000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 561100000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 37977550.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 2584700000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Work In Process: 760200000.00
MCHPP balance_sheet (quarterly, 2025-09-30) — Working Capital: 1306500000.00
MCHPP income_statement (quarterly, 2025-12-31) — +Operating Expense: 550400000.00
MCHPP income_statement (quarterly, 2025-12-31) — +Total Revenue: 1186000000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 160600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 697600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2552400000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4091200000.00
MCHPP income_statement (quarterly, 2025-12-31) — Amortization: 107600000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 134000000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 134000000.00
MCHPP income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 107600000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
MCHPP cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 236800000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 710700000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -22500000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -22500000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 38600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Capital Stock: 600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 250700000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 250700000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -273900000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -283000000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -44500000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 341400000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1400000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 11900000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Change In Inventory: 39000000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -16300000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Change In Payable: 10500000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 10500000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Change In Receivables: 15000000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 11900000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 48200000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 15000000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Changes In Cash: 13900000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Common Stock: 600000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -246100000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 6560400000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 12200000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 431500000.00
MCHPP income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 479100000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 223600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Current Assets: 2290600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 38600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 38600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 163000000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 163000000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1059300000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Current Provisions: 339500000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -15600000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Deferred Tax: -15600000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Depreciation: 37800000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 171800000.00
MCHPP income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 107600000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 171800000.00
MCHPP income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 107600000.00
MCHPP income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 34900000.00
MCHPP income_statement (quarterly, 2025-12-31) — EBIT: 148200000.00
MCHPP income_statement (quarterly, 2025-12-31) — EBITDA: 320000000.00
MCHPP cash_flow (quarterly, 2025-12-31) — End Cash Position: 250700000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -283000000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Finished Goods: 225100000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 318900000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -6700000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Goodwill: 6695500000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 8794600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Gross PPE: 3682400000.00
MCHPP income_statement (quarterly, 2025-12-31) — Gross Profit: 706900000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 0.00
MCHPP income_statement (quarterly, 2025-12-31) — Interest Expense: 54600000.00
MCHPP income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 54600000.00
MCHPP income_statement (quarterly, 2025-12-31) — Interest Income: 1300000.00
MCHPP income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1300000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Inventory: 1057700000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Invested Capital: 11926400000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -44500000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 12200000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2799100000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 99700000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 5366000000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5366000000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -1588400000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 649700000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2440500000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 12200000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Net Debt: 5115300000.00
MCHPP income_statement (quarterly, 2025-12-31) — Net Income: 62700000.00
MCHPP income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 34900000.00
MCHPP income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 62700000.00
MCHPP income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 62700000.00
MCHPP income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 62700000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 62700000.00
MCHPP income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 62700000.00
MCHPP income_statement (quarterly, 2025-12-31) — Net Interest Income: -54600000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -11700000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -938700000.00
MCHPP income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -54600000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -9600000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -22000000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Net PPE: 1130000000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -2234200000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1742500000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 29600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1742500000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 29600000.00
MCHPP income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 324800000.00
MCHPP income_statement (quarterly, 2025-12-31) — Normalized Income: 65915384.62
MCHPP cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 341400000.00
MCHPP income_statement (quarterly, 2025-12-31) — Operating Income: 156500000.00
MCHPP income_statement (quarterly, 2025-12-31) — Operating Revenue: 1186000000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 541132605.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 251000000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -6700000.00
MCHPP income_statement (quarterly, 2025-12-31) — Other Income Expense: -8300000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 2099100000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1700000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 367800000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 737500000.00
MCHPP income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -3500000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Other Receivables: 39200000.00
MCHPP income_statement (quarterly, 2025-12-31) — Other Special Charges: 4800000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Payables: 160600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 384200000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 134000000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
MCHPP cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -27800000.00
MCHPP income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 27800000.00
MCHPP income_statement (quarterly, 2025-12-31) — Pretax Income: 93600000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Raw Materials: 132700000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Receivables: 731200000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -5600000.00
MCHPP income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 414900000.00
MCHPP income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 171800000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -2810800000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
MCHPP income_statement (quarterly, 2025-12-31) — Research And Development: 274300000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 5046100000.00
MCHPP income_statement (quarterly, 2025-12-31) — Selling General And Administration: 168500000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Share Issued: 578423967.00
MCHPP income_statement (quarterly, 2025-12-31) — Special Income Charges: -4800000.00
MCHPP cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 72600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 6560400000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -2234200000.00
MCHPP income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -1584615.38
MCHPP income_statement (quarterly, 2025-12-31) — Tax Provision: 30900000.00
MCHPP income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.33
MCHPP balance_sheet (quarterly, 2025-12-31) — Total Assets: 14325500000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 11926400000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Total Debt: 5404600000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 6560400000.00
MCHPP income_statement (quarterly, 2025-12-31) — Total Expenses: 1029500000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 7765100000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 12034900000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6705800000.00
MCHPP income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 151700000.00
MCHPP income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 1300000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 0.00
MCHPP income_statement (quarterly, 2025-12-31) — Total Unusual Items: -4800000.00
MCHPP income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -4800000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 572700000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 37291362.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 2570800000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Work In Process: 699900000.00
MCHPP balance_sheet (quarterly, 2025-12-31) — Working Capital: 1231300000.00
MCHPP income_statement (annual, 2026-03-31) — +Operating Expense: 2191300000.00
MCHPP income_statement (quarterly, 2026-03-31) — +Operating Expense: 575800000.00
MCHPP income_statement (annual, 2026-03-31) — +Total Revenue: 4713100000.00
MCHPP income_statement (quarterly, 2026-03-31) — +Total Revenue: 1311200000.00
MCHPP balance_sheet (annual, 2026-03-31) — Accounts Payable: 205600000.00
MCHPP balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 205600000.00
MCHPP balance_sheet (annual, 2026-03-31) — Accounts Receivable: 889700000.00
MCHPP balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 889700000.00
MCHPP balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -2603800000.00
MCHPP balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -2603800000.00
MCHPP balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 4071500000.00
MCHPP balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 4071500000.00
MCHPP income_statement (annual, 2026-03-31) — Amortization: 431100000.00
MCHPP income_statement (quarterly, 2026-03-31) — Amortization: 107800000.00
MCHPP cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 534300000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 135000000.00
MCHPP cash_flow (annual, 2026-03-31) — Amortization Of Intangibles: 534300000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 135000000.00
MCHPP income_statement (annual, 2026-03-31) — Amortization Of Intangibles Income Statement: 431100000.00
MCHPP income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 107800000.00
MCHPP cash_flow (annual, 2026-03-31) — Asset Impairment Charge: 4100000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 1600000.00
MCHPP cash_flow (annual, 2026-03-31) — Beginning Cash Position: 771700000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 250700000.00
MCHPP balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 711000000.00
MCHPP balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 711000000.00
MCHPP cash_flow (annual, 2026-03-31) — Capital Expenditure: -91100000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -14200000.00
MCHPP cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: -91100000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -14200000.00
MCHPP balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 38800000.00
MCHPP balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 38800000.00
MCHPP balance_sheet (annual, 2026-03-31) — Capital Stock: 600000.00
MCHPP balance_sheet (quarterly, 2026-03-31) — Capital Stock: 600000.00
MCHPP balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 240300000.00
MCHPP balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 240300000.00
MCHPP balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 240300000.00
MCHPP balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 240300000.00
MCHPP cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -1092500000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -274400000.00
MCHPP cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1298000000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -215300000.00
MCHPP cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: -195500000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -52100000.00
MCHPP cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: 962100000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 257000000.00
MCHPP cash_flow (annual, 2026-03-31) — Change In Account Payable: 26000000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 53400000.00
MCHPP cash_flow (annual, 2026-03-31) — Change In Income Tax Payable: -147700000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 19800000.00
MCHPP cash_flow (annual, 2026-03-31) — Change In Inventory: 264300000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Change In Inventory: 24300000.00
MCHPP cash_flow (annual, 2026-03-31) — Change In Other Working Capital: -105800000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -13700000.00
MCHPP cash_flow (annual, 2026-03-31) — Change In Payable: -121700000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Change In Payable: 73200000.00
MCHPP cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: -121700000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 73200000.00
MCHPP cash_flow (annual, 2026-03-31) — Change In Receivables: -204500000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Change In Receivables: -163600000.00
MCHPP cash_flow (annual, 2026-03-31) — Change In Tax Payable: -147700000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 19800000.00
MCHPP cash_flow (annual, 2026-03-31) — Change In Working Capital: -167700000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -79800000.00
MCHPP cash_flow (annual, 2026-03-31) — Changes In Account Receivables: -204500000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -163600000.00
MCHPP cash_flow (annual, 2026-03-31) — Changes In Cash: -531400000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Changes In Cash: -10400000.00
MCHPP balance_sheet (annual, 2026-03-31) — Common Stock: 600000.00
MCHPP balance_sheet (quarterly, 2026-03-31) — Common Stock: 600000.00
MCHPP cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -984000000.00
MCHPP cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -246600000.00
MCHPP balance_sheet (annual, 2026-03-31) — Common Stock Equity: 6432400000.00
MCHPP balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6432400000.00